Full-Time
Associate Project Manager
Posted on 8/17/2026
Suvoda
1,001-5,000 employees
SaaS-driven IRT for clinical trials
No salary listed
Conshohocken, PA, USA
In Person
Travel to client sites is required for meetings and user training sessions.
Bachelor's
 Business & Strategy (1) |
|---|
Get referred to Suvoda
See people who can refer or advise you
- A bachelor's degree is required, with life sciences or computer science preferred.
- Interpersonal and communication skills are required.
- Time management and organizational skills are required.
- Analytical thinking ability is required.
- Creative problem-solving ability is required.
- Attention to detail is required.
- Applicants must be currently authorized to work in the United States on a full-time basis.
- Work as part of a cross-functional project team responsible for delivering Interactive Response Technology for randomization and drug supply management in clinical trials.
- Liaise with clients to discuss requirements, handle issues, provide status updates, and answer questions.
- Design Interactive Response Technology solutions based on clinical protocols, proposals, and client discussions.
- Document requirements accurately and completely and participate in internal and external specification review meetings.
- Assist with client review meetings of Interactive Response Technology specifications and supporting documents, making required updates.
- Manage project schedules and scope and track internal and client tasks required to meet project milestones.
- Manage the cross-functional project team's schedule and task assignments.
- Assist with creating the User Acceptance Testing plan, develop test scripts, coordinate data setup, and support clients during User Acceptance Testing.
- Provide protocol-specific support to clients and the support team after go-live.
- Ensure client satisfaction throughout the project build and maintenance phase, working with management, the product team, and business development as needed.
- Provide system training to end users through in-person meetings, web meetings, and user manuals.
- Provide telephone and email support to system users globally.
- Travel to client sites to attend meetings and conduct user training sessions.
- Perform other related duties as required.
Suvoda provides a modular SaaS platform for managing complex clinical trials through an IRT system that handles patient randomization, drug supply, and data collection. The product is subscription-based software that can be configured and deployed quickly, with modular components tailored to different study types and fast startup times. It also offers virtual trial capabilities, including direct-to-patient shipping, to keep studies running when in-person visits aren’t possible. Suvoda aims to help pharma, biotech, and CROs run complex trials more efficiently, speeding up the development and delivery of new treatments.
Company Size
1,001-5,000
Company Stage
Early VC
Total Funding
$40M
Headquarters
Conshohocken, Pennsylvania
Founded
2012
Get referred to Suvoda
See people who can refer or advise you
Simplify's Take
What believers are saying
- Suvoda launched a unified patient app on October 29, 2025, improving retention.
- Its 2026 Sofia assistant now accelerates study monitoring, alerts, and decision support.
- Revelio counted 1,333 employees in March 2026, with 116 active job postings.
What critics are saying
- Greenphire integration still strains product, sales, and support teams through 2026.
- Medidata and IQVIA crush pricing if Suvoda misses AI rollout quality.
- A major validation failure freezes trials and destroys sponsor trust overnight.
What makes Suvoda unique
- Suvoda's April 2026 agentic RTSM cuts kickoff-to-UAT to two weeks.
- Its September 2025 merger with Greenphire unifies IRT, eCOA, travel, and payments.
- Five U.S. patents and 6,000 trials across 115 countries signal niche depth.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 4%2 year growth
↑ 0%Suvoda patient app earns "best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards program. Landmark 10th annual Awards program recognizes the most innovative digital health and medical technology solutions worldwide. LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) - MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies, and products in the global digital health and medical technology market, today announced that Suvoda, a global leader in clinical trial technology, has been selected as winner of the "Best Patient Relationship Management Solution" award in the 10th annual MedTech Breakthrough Awards program. The 2026 MedTech Breakthrough Award recognizes the breakthrough innovation of Suvoda's patient app, which offers a single streamlined mobile experience where patients can manage the essentials of clinical trial participation. Patients in clinical trials often have to manage ongoing financial costs, frequent clinic visits, data reporting, and logistical coordination. These demands can place additional strain on patients, particularly those managing complex or serious conditions, as well as on the clinical sites responsible for supporting them. The Suvoda App centralizes key activities and details, connecting patients and sites through a single mobile experience that simplifies participation and improves communication. For example, patients can schedule visits, complete questionnaires about their health status, view travel details and itineraries, and manage payments, including uploading receipts on their own phones or tablets, or ones provided by the study sponsor if needed. Automated reminders and notifications keep participants on top of visits, questionnaires, and key tasks, helping studies stay on track. Self-serve, in-app scheduling lets patients pick available site appointment times within their visit windows, while calendar integrations will help them fit trial visits into their everyday schedules. Patients log in with a simple, secure sign-in and can access a dashboard with assigned tasks. Additionally, with the embedded Greenphire Patient Payments, patients can submit travel receipts and receive participation stipends and reimbursements quickly in their local currency. They can choose the payment method that works best for them, including direct-to-bank, and virtual or physical debit cards. "We built this app with patients in mind. How they think, what they need, and what makes things easier in their day-to-day lives," said Jagath Wanninayake, Suvoda CEO. "When everything is in one place and works the way people expect, it removes a lot of the friction that comes with trial participation. Thank you to MedTech Breakthrough for this recognition. We plan to keep focusing on making the trial experience more manageable and more human for everyone involved." Now celebrating its 10th anniversary, the MedTech Breakthrough Awards program has spent a decade recognizing the companies driving meaningful progress and improving patient care across the global health and medical technology industry. The program spans a wide range of categories - including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices and beyond - honoring the innovations reshaping how care is delivered worldwide. This year's program drew a record-breaking number of nominations from leading companies and startups across more than 20 countries, reflecting the growing global impact and momentum of the digital healthcare industry. "The Suvoda app unifies the tasks that matter most to clinical trial participants into one mobile experience. Most participants juggle multiple portals, apps, and communication channels just to complete basic study tasks. Hurdles, from time commitment and logistics to expenses, can deter trial participation, with most delays due to deficient recruitment and retention," said Steve Johansson, managing director, MedTech Breakthrough. "Where many patient engagement solutions solve one step of the journey, the Suvoda app centralizes key information and steps, significantly enhancing the trial experience so participants are more likely to stay enrolled in the trial. Congratulations on winning 'Best Patient Relationship Management Solution.'" About MedTech Breakthrough Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com. Tech Breakthrough LLC does not endorse any vendor, product or service depicted in its recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose. About Suvoda Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 6000 trials across more than 115 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.
Suvoda, a clinical trial technology company, has introduced agentic RTSM, an AI-powered system that reduces clinical trial startup timelines by up to 80%. The technology can take a study from project kickoff to User Acceptance Testing in as little as two weeks, compared to the months traditionally required. The system uses multiple AI agents to accelerate study builds, software configuration, customisation and testing. Built on Suvoda's patented platform, it leverages Virtual Partition architecture and low-code tools rather than rebuilding for each trial. Suvoda is working with early adopters to deploy the technology and plans to extend the agentic model to its eCOA and financial services products. The company, headquartered near Philadelphia, has supported over 6,000 trials across 115 countries.
Suvoda, a clinical trial technology company, has launched agentic RTSM, using AI to reduce clinical trial startup timelines by up to 80%. The system can take a study from project kickoff to User Acceptance Testing in as little as two weeks, compared to the months traditionally required. The technology employs multiple AI agents to accelerate study builds, software configuration, customisation and testing. Built on Suvoda's patented platform, it leverages virtual partition architecture and low-code tools, drawing on data from thousands of previous trials. Suvoda is currently working with early adopters to deploy the technology and plans to extend the agentic model to its eCOA and financial services products. The company also operates Sofia, an AI assistant being enhanced to support trial monitoring and alerts.
https://mma.prnewswire.com/media/1759317/5919669/Suvoda_updated_Logo.jpg. Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%. Next-generation, AI-powered Randomization and Trial Supply Management system - designed to get studies to first-patient-in significantly faster CONSHOHOCKEN, Pa., April 21, 2026 /PRNewswire/ - Getting a clinical trial from contract to go-live can take months. For sponsors working to deliver therapies to patients who need them, the startup window is one of the most persistent drags on timelines - and one of the hardest to compress. Today, Suvoda, a global clinical trial technology company and a recognized leader in the RTSM space, announced agentic RTSM: the next evolution of Suvoda IRT that uses agentic AI to take a study from project kickoff to User Acceptance Testing (UAT) in as little as two weeks. Agentic RTSM is part of a broader AI strategy that, together with Suvoda's AI assistant Sofia, delivers three outcomes for sponsors and study teams: * Accelerate study builds and startup timelines - reducing the kickoff to UAT timeline by up to 80% * Elevate the experience for sponsors and sites - giving faster access to trial information and reducing administrative burden * Deliver intelligent insights - giving study teams clearer visibility into trial status and smarter decision-making support In Suvoda RTSM, multiple AI agents accelerate distinct phases of the study build - including software configuration, customization, and testing - and speed up change orders. Because agentic RTSM is built on the patented Suvoda Platform, it leverages the Virtual Partition architecture and the code generation capabilities of the platform's low-code/no-code tools, rather than rebuilding from scratch for each build. It also drives rapid agentic setup through access to a shared data layer with comprehensive data on trial configurations that have been refined through Suvoda's experience with thousands of complex trials. This approach allows Suvoda's team to focus where it matters most: delivering expert consulting and calm guidance at every stage of the trial. "Clinical trials are only becoming more complex and more urgent, and our customers shouldn't have to deal with technology that slows them down," said Jagath Wanninayake, CEO, Suvoda. "With agentic RTSM, we're using AI to remove friction from trial startup - so sponsors can begin enrolling patients sooner, sites get a smarter and more responsive experience, and study teams spend less time on administrative tasks and more time on the work that matters." Suvoda is currently working with a select group of early adopters to deploy agentic RTSM capabilities, solidifying the operational and services foundation to support broader rollout. Suvoda is also enhancing Sofia, its AI assistant, to support monitoring, provide alerts, and take direct actions with appropriate safeguards to support the study process. The company plans to extend the agentic model to eCOA and its financial services products, bringing the same startup speed and consistency to questionnaire-based studies, to participant travel, and to patient and site payments. "Our goal is to make every moment in a trial smarter - whether we're building a complex RTSM system for a study, responding to a protocol amendment, or helping a site coordinator get the right answer in seconds," said E.K. Koh, Chief Product Officer, Suvoda. "Agentic RTSM is one of the first steps in a broader AI vision. Speed, quality, and experience don't have to be trade-offs - they can all move forward together." At the heart of Suvoda RTSM is a commitment to the people it serves: the sponsors testing new treatments, the sites running trials, and ultimately the patients waiting for therapies. Faster startup isn't just an operational metric - it's a step toward getting medicines to the people who need them sooner. ABOUT SUVODA Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 6,000 trials across more than 115 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.
Suvoda sets new standard for streamlined patient and site experience in clinical trials. CONSHOHOCKEN, Pa., Jan. 12, 2026 /PRNewswire/ - Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company's merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda's ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product innovation and deployment of AI tools, Suvoda closed the year with growing momentum toward a single, cohesive ecosystem that reduces complexity across the clinical trial lifecycle. "The last twelve months marked an important step forward for Suvoda," said Jagath Wanninayake, CEO of Suvoda. "Our teams worked with care and intention as we brought two strong companies together and delivered new capabilities that reflect what patients and sites actually need. As we enter 2026, we're focused on helping sponsors and sites navigate their trials with clarity while giving patients a smoother, more supportive experience." Making the patient journey easier A defining milestone of the year was the launch of Suvoda's patient app, a clear demonstration of how a unified platform can meaningfully improve the clinical trial experience for patients. The app brings eCOA questionnaires, patient payments, reminders, and visit scheduling into one consumer-grade interface that patients can use on their own devices. This advancement helps participants stay engaged while easing the administrative load for busy sites. Harnessing AI to alleviate administrative burden in clinical trials Suvoda also simplified how study teams access critical information with Sofia, an AI assistant currently deployed in Suvoda IRT with platform expansion in the future. Sofia helps users ask questions and get answers with a generative AI tool, replacing multi-step navigation with quick, clear responses. Built with strong privacy and role-based controls, Sofia supports everyday decision making for study teams without compromising data security or the integrity of the study blind. Suvoda's approach earned continued recognition in 2025, including a new patent for its platform architecture, bringing its total to five. Everest Group also named Suvoda a Leader in its RTSM PEAK Matrix(R) assessment. Across its portfolio, Suvoda released enhancements that improve transparency, data quality, and ease of use, reflecting its ongoing focus on practical innovation that supports real-world trial operations. The company anticipates continuing its strong growth in 2026 as pharmaceutical sponsors and CROs increasingly look for unified platforms that reduce trial complexity while supporting exceptional patient and site experiences. "We spent 2025 not only merging two companies, but unifying our technologies, our people, and our mission," Wanninayake said. "That foundation positions us to deliver even greater value in 2026 and beyond. We're ready to support sponsors and sites to meet more of their clinical trial needs and help patients move through their studies with ease and confidence." About Suvoda Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn. Logo - https://mma.prnasia.com/media2/1759317/Suvoda_updated_Logo.jpg?p=medium600 The information provided in this article was created by Cision PR Newswire, its news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Siam News Network.